Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in intermediate- and high-risk endometrial cancer.

[1]  M. Kaneuchi,et al.  Risk factors for lower-limb lymphedema after surgery for cervical cancer , 2011, International Journal of Clinical Oncology.

[2]  Y. Todo,et al.  Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. , 2010, Gynecologic oncology.

[3]  M. Kaneuchi,et al.  Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis , 2010, The Lancet.

[4]  J. Herod,et al.  Efficacy of Systematic Pelvic Lymphadenectomy in Endometrial Cancer (MRC ASTEC Trial): A Randomized Study , 2009, International Journal of Gynecologic Cancer.

[5]  A. V. D. Van Der Zee,et al.  Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. , 2009, Gynecologic oncology.

[6]  V. Torri,et al.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.

[7]  H. Sasaki,et al.  Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma , 2009, BMC Cancer.

[8]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[9]  C. Köhler,et al.  Lymph Edema of the Lower Extremities after Lymphadenectomy and Radiotherapy for Cervical Cancer , 2008, Strahlentherapie und Onkologie.

[10]  R. Barakat,et al.  Observations on the role of circumflex iliac node resection and the etiology of lower extremity lymphedema following pelvic lymphadenectomy for gynecologic malignancy. , 2007, Gynecologic oncology.

[11]  R. Barakat,et al.  The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. , 2006, Gynecologic oncology.

[12]  A. Berchuck,et al.  Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology , 2006 .

[13]  A. Berchuck,et al.  Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Hiroki Utsunomiya,et al.  Sentinel lymph node detection in patients with endometrial cancer. , 2004, Gynecologic oncology.

[15]  Isl Isl.  The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. , 2003, Lymphology.

[16]  Y. Taketani,et al.  Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas. , 2002, Cancer letters.

[17]  M. Witte,et al.  The diagnosis and treatment of peripheral lymphedema: draft revision of the 1995 Consensus Document of the International Society of Lymphology Executive Committee for discussion at the September 3-7, 2001, XVIII International Congress of Lymphology in Genoa, Italy. , 2001, Lymphology.

[18]  M. Hoffman,et al.  Distal external iliac lymph nodes in early cervical cancer. , 1999, Obstetrics and gynecology.

[19]  N. Sakuragi,et al.  Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy , 1999, Cancer.

[20]  P. Mortimer,et al.  The pathophysiology of lymphedema , 1998, Cancer.

[21]  M. Boris,et al.  Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. , 1997, Oncology.